B Cell Induction in Pediatric Lung Transplantation

NCT02266888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Lung Transplant

Interventions

BIOLOGICAL: Rituximab (Rituxan®)
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]